p97: An Emerging Target for Cancer, Neurodegenerative Diseases, and Viral Infections

The AAA+ ATPase, p97, also referred to as VCP, plays an essential role in cellular homeostasis by regulating endoplasmic reticulum-associated degradation (ERAD), mitochondrial-associated degradation (MAD), chromatin-associated degradation, autophagy, and endosomal trafficking. Mutations in p97 have...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2020-03, Vol.63 (5), p.1892-1907
Main Authors: Huryn, Donna M, Kornfilt, David J. P, Wipf, Peter
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a348t-a6ba2b91945a1451b6cbeb2db0e21765dbf9b55e7697d02da4e2c75cb92f1e1c3
cites cdi_FETCH-LOGICAL-a348t-a6ba2b91945a1451b6cbeb2db0e21765dbf9b55e7697d02da4e2c75cb92f1e1c3
container_end_page 1907
container_issue 5
container_start_page 1892
container_title Journal of medicinal chemistry
container_volume 63
creator Huryn, Donna M
Kornfilt, David J. P
Wipf, Peter
description The AAA+ ATPase, p97, also referred to as VCP, plays an essential role in cellular homeostasis by regulating endoplasmic reticulum-associated degradation (ERAD), mitochondrial-associated degradation (MAD), chromatin-associated degradation, autophagy, and endosomal trafficking. Mutations in p97 have been linked to a number of neurodegenerative diseases, and overexpression of wild type p97 is observed in numerous cancers. Furthermore, p97 activity has been shown to be essential for the replication of certain viruses, including poliovirus, herpes simplex virus (HSV), cytomegalovirus (CMV), and influenza. Taken together, these observations highlight the potential for targeting p97 as a therapeutic approach in neurodegeneration, cancer, and certain infectious diseases. This Perspective reviews recent advances in the discovery of small molecule inhibitors of p97, their optimization and characterization, and therapeutic potential.
doi_str_mv 10.1021/acs.jmedchem.9b01318
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2297127690</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2297127690</sourcerecordid><originalsourceid>FETCH-LOGICAL-a348t-a6ba2b91945a1451b6cbeb2db0e21765dbf9b55e7697d02da4e2c75cb92f1e1c3</originalsourceid><addsrcrecordid>eNp9kD1PwzAQhi0EoqXwDxDyyNCUOydOGraqlA-pgqWwRrZzCakap9gJEv-eQFtGphvufd7TPYxdIkwQBN4o4yfrmnLzTvUk1YAhTo_YEKWAIJpCdMyGAEIEIhbhgJ15vwaAEEV4ygYhSgkoYchW2zS55TPLFzW5srIlXylXUsuLxvG5sobcmD9T55qcSrLkVFt9Er-rPClPfsyVzflb5dSGP9mCTFs11p-zk0JtPF3s54i93i9W88dg-fLwNJ8tAxVG0zZQsVZCp5hGUmEkUcdGkxa5BhKYxDLXRaqlpCROkxxEriISJpFGp6JAQhOO2PWud-uaj458m9WVN7TZKEtN5zMh0gRFj0MfjXZR4xrvHRXZ1lW1cl8ZQvbjM-t9Zgef2d5nj13tL3S63_1BB4F9AHaBX7zpnO0f_r_zG1MmhC8</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2297127690</pqid></control><display><type>article</type><title>p97: An Emerging Target for Cancer, Neurodegenerative Diseases, and Viral Infections</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Huryn, Donna M ; Kornfilt, David J. P ; Wipf, Peter</creator><creatorcontrib>Huryn, Donna M ; Kornfilt, David J. P ; Wipf, Peter</creatorcontrib><description>The AAA+ ATPase, p97, also referred to as VCP, plays an essential role in cellular homeostasis by regulating endoplasmic reticulum-associated degradation (ERAD), mitochondrial-associated degradation (MAD), chromatin-associated degradation, autophagy, and endosomal trafficking. Mutations in p97 have been linked to a number of neurodegenerative diseases, and overexpression of wild type p97 is observed in numerous cancers. Furthermore, p97 activity has been shown to be essential for the replication of certain viruses, including poliovirus, herpes simplex virus (HSV), cytomegalovirus (CMV), and influenza. Taken together, these observations highlight the potential for targeting p97 as a therapeutic approach in neurodegeneration, cancer, and certain infectious diseases. This Perspective reviews recent advances in the discovery of small molecule inhibitors of p97, their optimization and characterization, and therapeutic potential.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.9b01318</identifier><identifier>PMID: 31550150</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>Journal of medicinal chemistry, 2020-03, Vol.63 (5), p.1892-1907</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a348t-a6ba2b91945a1451b6cbeb2db0e21765dbf9b55e7697d02da4e2c75cb92f1e1c3</citedby><cites>FETCH-LOGICAL-a348t-a6ba2b91945a1451b6cbeb2db0e21765dbf9b55e7697d02da4e2c75cb92f1e1c3</cites><orcidid>0000-0001-5542-4968 ; 0000-0001-7693-5863</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31550150$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Huryn, Donna M</creatorcontrib><creatorcontrib>Kornfilt, David J. P</creatorcontrib><creatorcontrib>Wipf, Peter</creatorcontrib><title>p97: An Emerging Target for Cancer, Neurodegenerative Diseases, and Viral Infections</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>The AAA+ ATPase, p97, also referred to as VCP, plays an essential role in cellular homeostasis by regulating endoplasmic reticulum-associated degradation (ERAD), mitochondrial-associated degradation (MAD), chromatin-associated degradation, autophagy, and endosomal trafficking. Mutations in p97 have been linked to a number of neurodegenerative diseases, and overexpression of wild type p97 is observed in numerous cancers. Furthermore, p97 activity has been shown to be essential for the replication of certain viruses, including poliovirus, herpes simplex virus (HSV), cytomegalovirus (CMV), and influenza. Taken together, these observations highlight the potential for targeting p97 as a therapeutic approach in neurodegeneration, cancer, and certain infectious diseases. This Perspective reviews recent advances in the discovery of small molecule inhibitors of p97, their optimization and characterization, and therapeutic potential.</description><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kD1PwzAQhi0EoqXwDxDyyNCUOydOGraqlA-pgqWwRrZzCakap9gJEv-eQFtGphvufd7TPYxdIkwQBN4o4yfrmnLzTvUk1YAhTo_YEKWAIJpCdMyGAEIEIhbhgJ15vwaAEEV4ygYhSgkoYchW2zS55TPLFzW5srIlXylXUsuLxvG5sobcmD9T55qcSrLkVFt9Er-rPClPfsyVzflb5dSGP9mCTFs11p-zk0JtPF3s54i93i9W88dg-fLwNJ8tAxVG0zZQsVZCp5hGUmEkUcdGkxa5BhKYxDLXRaqlpCROkxxEriISJpFGp6JAQhOO2PWud-uaj458m9WVN7TZKEtN5zMh0gRFj0MfjXZR4xrvHRXZ1lW1cl8ZQvbjM-t9Zgef2d5nj13tL3S63_1BB4F9AHaBX7zpnO0f_r_zG1MmhC8</recordid><startdate>20200312</startdate><enddate>20200312</enddate><creator>Huryn, Donna M</creator><creator>Kornfilt, David J. P</creator><creator>Wipf, Peter</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5542-4968</orcidid><orcidid>https://orcid.org/0000-0001-7693-5863</orcidid></search><sort><creationdate>20200312</creationdate><title>p97: An Emerging Target for Cancer, Neurodegenerative Diseases, and Viral Infections</title><author>Huryn, Donna M ; Kornfilt, David J. P ; Wipf, Peter</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a348t-a6ba2b91945a1451b6cbeb2db0e21765dbf9b55e7697d02da4e2c75cb92f1e1c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Huryn, Donna M</creatorcontrib><creatorcontrib>Kornfilt, David J. P</creatorcontrib><creatorcontrib>Wipf, Peter</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Huryn, Donna M</au><au>Kornfilt, David J. P</au><au>Wipf, Peter</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>p97: An Emerging Target for Cancer, Neurodegenerative Diseases, and Viral Infections</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2020-03-12</date><risdate>2020</risdate><volume>63</volume><issue>5</issue><spage>1892</spage><epage>1907</epage><pages>1892-1907</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>The AAA+ ATPase, p97, also referred to as VCP, plays an essential role in cellular homeostasis by regulating endoplasmic reticulum-associated degradation (ERAD), mitochondrial-associated degradation (MAD), chromatin-associated degradation, autophagy, and endosomal trafficking. Mutations in p97 have been linked to a number of neurodegenerative diseases, and overexpression of wild type p97 is observed in numerous cancers. Furthermore, p97 activity has been shown to be essential for the replication of certain viruses, including poliovirus, herpes simplex virus (HSV), cytomegalovirus (CMV), and influenza. Taken together, these observations highlight the potential for targeting p97 as a therapeutic approach in neurodegeneration, cancer, and certain infectious diseases. This Perspective reviews recent advances in the discovery of small molecule inhibitors of p97, their optimization and characterization, and therapeutic potential.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>31550150</pmid><doi>10.1021/acs.jmedchem.9b01318</doi><tpages>16</tpages><orcidid>https://orcid.org/0000-0001-5542-4968</orcidid><orcidid>https://orcid.org/0000-0001-7693-5863</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2020-03, Vol.63 (5), p.1892-1907
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_2297127690
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
title p97: An Emerging Target for Cancer, Neurodegenerative Diseases, and Viral Infections
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T14%3A59%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=p97:%20An%20Emerging%20Target%20for%20Cancer,%20Neurodegenerative%20Diseases,%20and%20Viral%20Infections&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Huryn,%20Donna%20M&rft.date=2020-03-12&rft.volume=63&rft.issue=5&rft.spage=1892&rft.epage=1907&rft.pages=1892-1907&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.9b01318&rft_dat=%3Cproquest_cross%3E2297127690%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a348t-a6ba2b91945a1451b6cbeb2db0e21765dbf9b55e7697d02da4e2c75cb92f1e1c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2297127690&rft_id=info:pmid/31550150&rfr_iscdi=true